Baird Medical Investment Holdings Limited Cash Flow Reinvestment Rate
Baird Medical Investment Holdings Limited cash flow reinvestment rate. Baird Medical Investment Holdings Limited (BDMD) has a Cash Flow Reinvestment Rate of 1.97x as of June 2023, reinvesting $1.26 Million (capex $1.26 Million ) from operating cash flow of $642.95K. See financial flexibility index of Baird Medical Investment Holdings Limite to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Baird Medical Investment Holdings Limited (2019–2022)
Cash flow reinvestment rate of Baird Medical Investment Holdings Limited from 2019 to 2022. Historical reinvestment intensity for Baird Medical Investment Holdings Limited across 4 annual periods. Explore Baird Medical Investment Holdings Limite cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Baird Medical Investment Holdings Limited Cash Flow Reinvestment Rate by Year (2019–2022)
Baird Medical Investment Holdings Limited cash flow reinvestment rate by year from 2019 to 2022. Year-by-year capital reinvestment analysis for Baird Medical Investment Holdings Limited. For the full cash flow conversion analysis, see Baird Medical Investment Holdings Limite operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 24.44x | $11.88 Million | $485.97K | $5.95 Million | ▲ +4528.2% |
| 2021 | 0.53x | $2.77 Million | $5.26 Million | $1.39 Million | ▲ +214.8% |
| 2020 | 0.17x | $655.35K | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $983.78K | $4.41 Million | $983.78K | — |